154 related articles for article (PubMed ID: 24031030)
1. DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women.
Ermel AC; Shew ML; Weaver BA; Qadadri B; Denski C; Tu W; Tong Y; Fortenberry JD; Brown DR
Sex Transm Infect; 2014 Feb; 90(1):64-9. PubMed ID: 24031030
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics.
Skjeldestad FE; Mehta V; Sings HL; Øvreness T; Turpin J; Su L; Boerckel P; Roberts C; Bryan J; Jansen KU; Esser MT; Liaw KL
Acta Obstet Gynecol Scand; 2008; 87(1):81-8. PubMed ID: 17943470
[TBL] [Abstract][Full Text] [Related]
3. Predictors of seropositivity to human papillomavirus type 53: one of the most prevalent high risk-related cervical human papillomaviruses.
Malik ZA; Hailpern SM; Burk RD
Viral Immunol; 2008 Sep; 21(3):371-7. PubMed ID: 18681800
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of Human Papillomavirus (HPV) Type 6, 11, 16, 18, by Anatomic Site of HPV Infection, in Women Aged 16-64 Years living in the Metropolitan Area of San Juan, Puerto Rico.
Pérez-Caraballo AM; Suarez E; Unger ER; Palefsky JM; Panicker G; Ortiz AP
P R Health Sci J; 2018 Mar; 37(1):26-31. PubMed ID: 29547681
[TBL] [Abstract][Full Text] [Related]
5. Association of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women.
Tong Y; Ermel A; Tu W; Shew M; Brown DR
J Med Virol; 2013 Oct; 85(10):1786-93. PubMed ID: 23861239
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus (HPV) DNA Detection Using Self-Sampling Devices in Women Undergoing Long Term Immunosuppressive Therapy.
Wielgos A; Pietrzak B; Sikora M; Martirosian G; Suchonska B; Gozdowska J; Oldakowska-Jedynak U; Jabiry-Zieniewicz Z; Durlik M; Rudnicka L; Wielgos M
Viruses; 2020 Aug; 12(9):. PubMed ID: 32872666
[TBL] [Abstract][Full Text] [Related]
7. Age-specific seroprevalence of human papillomavirus 16, 18, 31, and 58 in women of a rural town of Colombia.
Bedoya AM; Gaviria AM; Baena A; Borrero M; Duarte DF; Combita AL; Castaño J; Grisales H; Sánchez GI
Int J Gynecol Cancer; 2012 Feb; 22(2):303-10. PubMed ID: 22228426
[TBL] [Abstract][Full Text] [Related]
8. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
Garland SM; Cornall AM; Brotherton JML; Wark JD; Malloy MJ; Tabrizi SN;
Vaccine; 2018 May; 36(23):3221-3230. PubMed ID: 29724506
[TBL] [Abstract][Full Text] [Related]
9. Oral human papillomavirus infection in men might contribute to HPV serology.
Syrjänen S; Waterboer T; Kero K; Rautava J; Syrjänen K; Grenman S; Pawlita M
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):237-45. PubMed ID: 25116322
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.
Markowitz LE; Sternberg M; Dunne EF; McQuillan G; Unger ER
J Infect Dis; 2009 Oct; 200(7):1059-67. PubMed ID: 19719390
[TBL] [Abstract][Full Text] [Related]
11. A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination.
Batmunkh T; Dalmau MT; Munkhsaikhan ME; Khorolsuren T; Namjil N; Surenjav U; Toh ZQ; Licciardi PV; Russell FM; Garland SM; Mulholland K; von Mollendorf C
Vaccine; 2020 Jun; 38(27):4316-4324. PubMed ID: 32387009
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR].
Sahiner F; Gümral R; Sener K; Yiğit N; Dede M; Yapar M; Kubar A
Mikrobiyol Bul; 2012 Oct; 46(4):624-36. PubMed ID: 23188576
[TBL] [Abstract][Full Text] [Related]
13. High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands.
Vos RA; Pasmans H; Tymchenko L; Janga-Jansen AVA; Baboe-Kalpoe S; Hulshof K; de Melker HE; van der Klis FRM
Vaccine; 2020 Mar; 38(13):2816-2826. PubMed ID: 32088019
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
[TBL] [Abstract][Full Text] [Related]
15. Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review.
Tiggelaar SM; Lin MJ; Viscidi RP; Ji J; Smith JS
J Adolesc Health; 2012 Feb; 50(2):110-31. PubMed ID: 22265107
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human papillomavirus in saliva and cervix of sexually active women.
Adamopoulou M; Vairaktaris E; Nkenke E; Avgoustidis D; Karakitsos P; Sioulas V; Nisyrios T; Yapijakis C
Gynecol Oncol; 2013 May; 129(2):395-400. PubMed ID: 23428459
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coverage.
Gray P; Kann H; Pimenoff VN; Adhikari I; Eriksson T; Surcel HM; Vänskä S; Dillner J; Faust H; Lehtinen M
Int J Cancer; 2020 Dec; 147(12):3511-3522. PubMed ID: 32574384
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico.
Ortiz AP; Tortolero-Luna G; Romaguera J; Pérez CM; González D; Muñoz C; González L; Marrero E; Suárez E; Palefsky JM; Panicker G; Unger ER
Papillomavirus Res; 2018 Jun; 5():109-113. PubMed ID: 29555601
[TBL] [Abstract][Full Text] [Related]
19. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
[TBL] [Abstract][Full Text] [Related]
20. High prevalence and incidence of human papillomavirus in a cohort of healthy young African female subjects.
Watson-Jones D; Baisley K; Brown J; Kavishe B; Andreasen A; Changalucha J; Mayaud P; Kapiga S; Gumodoka B; Hayes RJ; de Sanjosé S
Sex Transm Infect; 2013 Aug; 89(5):358-65. PubMed ID: 23486859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
